Benign Prostatic Hypertrophy (BPH) is an enlargement of the prostate gland that occurs in most men over the age of 50. ProstaCol is designed to address the symptoms of BPH and to reduce COX-2 and 5-lipoxygenase-mediated prostate inflammation.
ProstaCol combines beta sitosterol with saw palmetto, pygeum africanum, stinging nettle and lycopene, all recognized for their ability to support healthy prostate function and to promote proper urinary flow.